We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
Cap. Flow
+$859M
Cap. Flow %
5.88%
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$90.3M
2
AMGN icon
Amgen
AMGN
+$88.7M
3
ALL icon
Allstate
ALL
+$52.2M
4
UNP icon
Union Pacific
UNP
+$47.1M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$44.7M

Sector Composition

Rank Sector Weight
1 Healthcare 33.42%
2 Technology 23.2%
3 Consumer Discretionary 9.14%
4 Financials 8.63%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWK icon
51
American Water Works
AWK
$26.3B
$60.1M 0.41%
389,969
+71,517
+22% +$11.1M
ON icon
52
ON Semiconductor
ON
$33.8B
$58.3M 0.4%
1,522,265
+234,356
+18% +$9.2M
INCY icon
53
Incyte
INCY
$23.5B
$56.5M 0.39%
671,894
+98,596
+17% +$8.22M
TX icon
54
Ternium
TX
$9.29B
$56.4M 0.39%
1,454,000
+655,800
+82% +$25M
VZ icon
55
Verizon
VZ
$194B
$56.2M 0.38%
1,002,577
+337,576
+51% +$19.4M
MCD icon
56
McDonald's
MCD
$188B
$55.9M 0.38%
241,929
+191,489
+380% +$44.6M
MRTX
57
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$55.8M 0.38%
345,596
+156,496
+83% +$25.1M
ANSS
58
DELISTED
Ansys
ANSS
$53.6M 0.37%
154,571
+50,907
+49% +$17.6M
MA icon
59
Mastercard
MA
$477B
$53.5M 0.37%
146,447
+12,943
+10% +$4.81M
LOW icon
60
Lowe's Companies
LOW
$116B
$53.4M 0.37%
275,377
+30,318
+12% +$5.93M
EL icon
61
Estee Lauder
EL
$29B
$51.1M 0.35%
160,542
+68,772
+75% +$20.9M
EXEL icon
62
Exelixis
EXEL
$13.9B
$50.4M 0.35%
2,767,947
+458,568
+20% +$10.7M
BLD
63
DELISTED
TopBuild
BLD
$50.2M 0.34%
253,749
+70,428
+38% +$14.6M
KO icon
64
Coca-Cola
KO
$354B
$49.9M 0.34%
921,581
+240,349
+35% +$13.1M
BKNG icon
65
Booking.com
BKNG
$138B
$49.4M 0.34%
564,225
+417,550
+285% +$39M
OC icon
66
Owens Corning
OC
$11.5B
$49M 0.34%
486,973
+412,191
+551% +$41.2M
IQV icon
67
IQVIA
IQV
$34.7B
$48.9M 0.33%
201,680
+187,677
+1,340% +$43.3M
MXIM
68
DELISTED
Maxim Integrated Products
MXIM
$48.5M 0.33%
460,606
+262,923
+133% +$25.7M
TXN icon
69
Texas Instruments
TXN
$255B
$48.4M 0.33%
251,919
+77,897
+45% +$14.6M
JPM icon
70
JPMorgan Chase
JPM
$939B
$47.5M 0.33%
305,267
-88,626
-23% -$13.9M
PTC icon
71
PTC
PTC
$13.7B
$46.5M 0.32%
329,110
+23,071
+8% +$3.15M
ADI icon
72
Analog Devices
ADI
$181B
$45.1M 0.31%
261,941
-175,513
-40% -$28.1M
ONC
73
BeOne Medicines Ltd
ONC
$33.8B
$44.8M 0.31%
130,595
-60,749
-32% -$20.1M
EQIX icon
74
Equinix
EQIX
$107B
$44M 0.3%
54,848
-31,715
-37% -$23.6M
NIO icon
75
NIO
NIO
$11.3B
$43.5M 0.3%
817,916
+456,467
+126% +$18.3M

Similar funds

Candriam SCA's Q2 2021 Portfolio in Review

As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.

  • Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
  • Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
  • Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
  • Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
  • Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
  • Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.

Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.